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Introduction 
Apocrine hidrocystoma is a rare, benign, cyst of 
proliferating apocrine glands often found in the 
periorbital area as a solitary, translucent, blue-
appearing nodule [1]. Owing to its distinctive  
morphology and pathology, it rarely presents as a 
diagnostic conundrum. The malignant counterpart is 
apocrine adenocarcinoma, a rare entity found in 
areas of high apocrine gland density, mainly in the 
axilla and anogenital region. However, there have 
been cases in the eyelid arising from Moll’s glands, 
scalp, nipple, lip, and others [2-5]. Co-occurrence of 
apocrine adenocarcinoma and hidrocystoma is 
extremely rare and has only been reported in 5 cases 
[6]. There is a paucity of literature on apocrine 
adenocarcinoma within a precursor apocrine 
hidrocystoma. Therefore, prognosis and treatment 
remain controversial. We present a patient with 
apocrine adenocarcinoma arising in a pre-existing 
apocrine hidrocystoma of the leg. To our knowledge, 
this is the first report of this unique pathology in the 
lower extremity. 
 
Case Synopsis 
A 48-year-old man presented with a right calf mass 
of two years’ duration, with accelerated growth over 
the past year. Six months prior to presentation, 
sonography demonstrated a 3.7cm subcutaneous 
mass suggestive of an epidermal inclusion cyst. 
Incision and debridement expressed dark red fluid 
suggestive of an old hematoma. He was referred to 
the senior author for further evaluation. On exam, 
the calf lesion was cystic, non-tender, with a blue 
discoloration, and without erythema, drainage, or a 
palpable thrill. The patient presented concurrently 
with a right ankle mass of 4-5 years’ initially  
Abstract 
Apocrine hidrocystoma is a benign, cystic lesion 
often presenting in the periorbital region. Apocrine 
adenocarcinoma is the rare, malignant counterpart 
occurring mainly in the axilla and anogenital region. 
There is a paucity of literature on both entities and 
co-occurrence has been reported in only 5 cases. We 
present the case of a 48-year-old man with a history 
of total body irradiation for chronic myelocytic 
leukemia, diabetes mellitus, and obesity who 
presented with a calf mass of two years’ duration. 
Epidermal inclusion cyst was presumed and 
excisional biopsy was carried out. Pathologic analysis 
revealed apocrine adenocarcinoma in the setting of 
a precursor apocrine hidrocystoma. Our patient’s 
unique altered immunity and the direct effects of 
irradiation on the local microenvironment may have 
resulted in his rare presentation of co-occurrence of 
apocrine adenocarcinoma within an existing 
apocrine hidrocystoma. To our knowledge, our 
patient is the first reported patient with this 
presentation in the lower extremity. 
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diagnosed as a ganglion cyst. On exam, the ankle 
mass was firm, non-tender, and non-translucent 
(Figure 1). 
The patient had a distant history of chronic 
myelocytic leukemia treated with bone marrow 
transplant after total body irradiation complicated 
by graft versus host disease, class II obesity (BMI 
36.82), type 2 diabetes mellitus, hypertension, 
hypertriglyceridemia, hypogonadism, obstructive 
sleep apnea, gout, trigeminal neuralgia, depression, 
and obsessive-compulsive disorder. His surgical 
history was notable for cholecystectomy and 
bilateral cataract surgery. Social history was 
noncontributory. Family history included type 2 
diabetes in both parents and colorectal 
adenocarcinoma in his father. 
Preoperative MRI revealed a non-enhancing mass in 
the medial calf subcutaneous soft tissues with 
intrinsic marked T1 hyperintensity suggestive of 
internal hemorrhage or keratinous products of an 
epidermal inclusion cyst. The patient was scheduled 
for excisional biopsy. 
An elliptical excision circumscribing the calf mass, 
which measured 6×7cm, was performed (Figure 1). 
A liquified hematoma was identified. The capsule 
was thin, friable, and not adherent to the deep 
structures. The incision was closed primarily. The 
ankle mass was excised via an elliptical incision and 
closed primarily. 
Light microscopy of the calf mass showed a well-
circumscribed, large, cystic structure lined by bland-
appearing epithelium with classic cytopathic 
changes of apocrine differentiation (Figure 2A). In 
particular, the cells demonstrated abundant 
eosinophilic cytoplasm with decapitation secretion 
(Figure 2B). In some areas, however, the epithelial 
lining was multilayered with supervening atypia 
(Figure 2C). In such foci, irregular nests of glandular 
epithelium assumed an infiltrative growth pattern 
into the surrounding stroma (Figure 2D). There was 
marked cellular atypia, cell necrosis, and scattered 
atypical mitotic figures.   
Subsequent to diagnosis, wide local excision of the 
tumor cavity site with 2cm margins was performed 
with negative margins. The lesion was closed with a 
rotational flap (Figure 3). He has since been 
evaluated by the hematology-oncology and 
   
 
Figure 2. Pathology. A) Low power magnification demonstrated a large epithelial lined cyst within the dermis; there was evidence of 
trauma characterized by fibrosis and neovascularization. Higher power magnification demonstrated an apocrine cytomorphology. H&E, 
20×. B) The cells lining the cyst wall exhibited abundant eosinophilic cytoplasm with a decapitation pattern of secretion. H&E, 400×. C) 
In areas, however, the cyst wall showed significant epithelial hyperplasia with supervening atypia including such foci juxtaposed to 
blander areas of conventional apocrine hidrocystoma. H&E, 200×. D) Areas of infiltrative growth were identified in the surrounding 
fibrous stroma. H&E, 100×. 
A B C D 
 
Figure 1. A) Patient presented with a large, hemorrhagic mass 
in the right medial calf as well as a mass in the posteromedial 
right ankle overlying the Achilles tendon. B) The calf mass was 
soft, mobile, non-tender, with a blue/purple discoloration.
A B 
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radiation-oncology departments for PET-CT scan and 
stringent screening, though no systemic therapy will 
be undertaken as he has no evidence of metastatic 
disease. 
 
Case Discussion 
Apocrine hidrocystoma is a rare, benign, cysts of the 
secretory portion of the apocrine coil. They are most 
frequent along the eyelid margin, presumably 
arising from the glands of Moll, but also found in the 
scalp, trunk, and extremities [1, 7]. These lesions are 
typically solitary and found in adults 30-70 years-old. 
These benign masses are treated by simple needle 
puncture, although other methods including 
electrodessication have been described [1, 8]. 
The reported incidence of apocrine adenocarcinoma 
is approximately one in 6-20million patients per year 
[4]. The median patient age is 67 without racial or 
gender preference [4, 5]. They are found in areas of 
high apocrine sweat gland density, mainly in the 
axilla and anogenital region, but also reported in the 
eyelid, scalp, nipple, lip, and others [4, 5, 9-12]. They 
may be solid or cystic masses and grow slowly with 
median preoperative duration of 12 months [13]. 
Current therapy recommends wide local excision 
with 1-2cm margins and lymph node exploration if 
clinically positive [4]. In cases without lymph node 
disease, use of adjuvant chemoradiation is 
controversial [4]. Local recurrence and metastatic 
disease can occur [4]. 
Co-occurrence of apocrine adenocarcinoma and 
hidrocystoma is extremely rare and has only been 
reported in 5 cases, all in the axilla of elderly 
Japanese men [6]. The morphologic hallmark of 
these neoplasms were areas of infiltrating carcinoma 
arising in a background of apocrine hidrocystoma. 
Two cases demonstrated regional lymph node 
metastasis and one patient had cutaneous 
recurrence of the tumor 38 months after the initial 
surgery and expired from respiratory insufficiency. 
All other patients were alive at 22-46 months follow 
up [6]. 
To our knowledge, our patient is the first reported 
case of an apocrine adenocarcinoma in a precursor 
apocrine hidrocystoma in the lower extremity. The 
patient’s history of CML and TBI were risk factors for 
the development of this rare malignancy, especially 
since he had experienced other side effects of TBI 
treatment, including cataract, hypogonadism, and 
dyslipidemia [14]. Secondary cancer is a known 
complication of TBI, though there have been no 
reports of apocrine adenocarcinoma [14, 15]. Given 
the previous irradiation, chronic inflammatory 
conditions including diabetes and obesity, personal 
and family history of carcinomas, we surmise that our 
patient is at risk for recurrent and distant metastatic 
disease. He will continue to undergo frequent 
monitoring with regular 18F-FDG PET/CT [16]. 
The interplay between the patient’s altered 
immunity from both iatrogenic and endogenous 
immune dysregulation along with the effects of TBI 
on the local microenvironment are likely oncogenic 
factors that facilitated malignant transformation. 
However, the exact oncogenic events remain elusive. 
This case underscores the importance in recognizing 
that all forms of neoplasia have the potential for 
malignant transformation, especially when the 
natural tumor surveillance mechanisms become 
impaired. 
 
Potential conflicts of interest 
The authors declare no conflicts of interests/[the 
following potential conflicts]. 
 
 
 
 
 
 
Figure 3. A) The previously created tumor cavity site was excised 
in an elliptical fashion measuring approximately 12×4cm. B) On 
postoperative day 71/43, the fasciocutaneous advancement flap 
healed well without any recurrence of calf mass appreciated on 
clinical examination. 
anterior 
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